PU_NN
.1_CD
-LRB-_-LRB-
Spi-1_NN
-RRB-_-RRB-
and_CC
C\/EBP_NN
alpha_NN
regulate_VBP
expression_NN
of_IN
the_DT
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
receptor_NN
alpha_NN
gene_NN
._.

Growth_NN
factor_NN
receptors_NNS
play_VBP
an_DT
important_JJ
role_NN
in_IN
hematopoiesis_NN
._.

In_IN
order_NN
to_TO
further_RB
understand_VB
the_DT
mechanisms_NNS
directing_VBG
the_DT
expression_NN
of_IN
these_DT
key_JJ
regulators_NNS
of_IN
hematopoiesis_NN
,_,
we_PRP
initiated_VBD
a_DT
study_NN
investigating_VBG
the_DT
transcription_NN
factors_NNS
activating_VBG
the_DT
expression_NN
of_IN
the_DT
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
GM-CSF_NN
-RRB-_-RRB-
receptor_NN
alpha_NN
gene_NN
._.

Here_RB
,_,
we_PRP
demonstrate_VBP
that_IN
the_DT
human_JJ
GM-CSF_NN
receptor_NN
alpha_NN
promoter_NN
directs_VBZ
reporter_NN
gene_NN
activity_NN
in_IN
a_DT
tissue-specific_JJ
fashion_NN
in_IN
myelomonocytic_JJ
cells_NNS
,_,
which_WDT
correlates_VBZ
with_IN
its_PRP$
expression_NN
pattern_NN
as_IN
analyzed_VBN
by_IN
reverse_JJ
transcription_NN
PCR_NN
._.

The_DT
GM-CSF_NN
receptor_NN
alpha_NN
promoter_NN
contains_VBZ
an_DT
important_JJ
functional_JJ
site_NN
between_IN
positions_NNS
-53_CD
and_CC
-41_CD
as_IN
identified_VBN
by_IN
deletion_NN
analysis_NN
of_IN
reporter_NN
constructs_NNS
._.

We_PRP
show_VBP
that_IN
the_DT
myeloid_JJ
and_CC
B_NN
cell_NN
transcription_NN
factor_NN
PU_NN
.1_CD
binds_VBZ
specifically_RB
to_TO
this_DT
site_NN
._.

Furthermore_RB
,_,
we_PRP
demonstrate_VBP
that_IN
a_DT
CCAAT_NN
site_NN
located_JJ
upstream_JJ
of_IN
the_DT
PU_NN
.1_CD
site_NN
between_IN
positions_NNS
-70_CD
and_CC
-54_CD
is_VBZ
involved_VBN
in_IN
positive-negative_JJ
regulation_NN
of_IN
the_DT
GM-CSF_NN
receptor_NN
alpha_NN
promoter_NN
activity_NN
._.

C\/EBP_NN
alpha_NN
is_VBZ
the_DT
major_JJ
CCAAT\/enhancer-binding_JJ
protein_NN
-LRB-_-LRB-
C\/EBP_NN
-RRB-_-RRB-
form_NN
binding_NN
to_TO
this_DT
site_NN
in_IN
nuclear_JJ
extracts_NNS
of_IN
U937_NN
cells_NNS
._.

Point_NN
mutations_NNS
of_IN
either_CC
the_DT
PU_NN
.1_CD
site_NN
or_CC
the_DT
C\/EBP_NN
site_NN
that_WDT
abolish_VBP
the_DT
binding_NN
of_IN
the_DT
respective_JJ
factors_NNS
result_VBP
in_IN
a_DT
significant_JJ
decrease_NN
of_IN
GM-CSF_NN
receptor_NN
alpha_NN
promoter_NN
activity_NN
in_IN
myelomonocytic_JJ
cells_NNS
only_RB
._.

Furthermore_RB
,_,
we_PRP
demonstrate_VBP
that_IN
in_IN
myeloid_JJ
and_CC
B_NN
cell_NN
extracts_NNS
,_,
PU_NN
.1_CD
forms_VBZ
a_DT
novel_JJ
,_,
specific_JJ
,_,
more_RBR
slowly_RB
migrating_VBG
complex_NN
-LRB-_-LRB-
PU-SF_NN
-RRB-_-RRB-
when_WRB
binding_VBG
the_DT
GM-CSF_NN
receptor_NN
alpha_NN
promoter_NN
PU_NN
.1_CD
site_NN
._.

This_DT
is_VBZ
the_DT
first_JJ
demonstration_NN
of_IN
a_DT
specific_JJ
interaction_NN
with_IN
PU_NN
.1_CD
on_IN
a_DT
myeloid_JJ
PU_NN
.1_CD
binding_NN
site_NN
._.

The_DT
novel_JJ
complex_NN
is_VBZ
distinct_JJ
from_IN
that_DT
described_VBN
previously_RB
as_IN
binding_NN
to_TO
B_NN
cell_NN
enhancer_NN
sites_NNS
and_CC
can_MD
be_VB
formed_VBN
by_IN
addition_NN
of_IN
PU_NN
.1_CD
to_TO
extracts_NNS
from_IN
certain_JJ
nonmyeloid_JJ
cell_NN
types_NNS
which_WDT
do_VBP
not_RB
express_VB
PU_NN
.1_CD
,_,
including_VBG
T_NN
cells_NNS
and_CC
epithelial_JJ
cells_NNS
,_,
but_CC
not_RB
from_IN
erythroid_JJ
cells_NNS
._.

Furthermore_RB
,_,
we_PRP
demonstrate_VBP
that_IN
the_DT
PU-SF_NN
complex_NN
binds_VBZ
to_TO
PU_NN
.1_CD
sites_NNS
found_VBN
on_IN
a_DT
number_NN
of_IN
myeloid_JJ
promoters_NNS
,_,
and_CC
its_PRP$
formation_NN
requires_VBZ
an_DT
intact_JJ
PU_NN
.1_CD
site_NN
adjacent_JJ
to_TO
a_DT
single-stranded_JJ
region_NN
._.

Expression_NN
of_IN
PU_NN
.1_CD
in_IN
nonmyeloid_JJ
cells_NNS
can_MD
activate_VB
the_DT
GM-CSF_NN
receptor_NN
alpha_NN
promoter_NN
._.

Deletion_NN
of_IN
the_DT
amino-terminal_JJ
region_NN
of_IN
PU_NN
.1_CD
results_VBZ
in_IN
a_DT
failure_NN
to_TO
form_VB
the_DT
PU-SF_NN
complex_NN
and_CC
in_IN
a_DT
concomitant_JJ
loss_NN
of_IN
transactivation_NN
,_,
suggesting_VBG
that_IN
formation_NN
of_IN
the_DT
PU-SF_NN
complex_NN
is_VBZ
of_IN
functional_JJ
importance_NN
for_IN
the_DT
activity_NN
of_IN
the_DT
GM-CSF_NN
receptor_NN
alpha_NN
promoter_NN
._.

Finally_RB
,_,
we_PRP
demonstrate_VBP
that_IN
C\/EBP_NN
alpha_NN
can_MD
also_RB
active_JJ
the_DT
GM-CSF_NN
receptor_NN
alpha_NN
promoter_NN
in_IN
nonmyeloid_JJ
cells_NNS
._.

-LRB-_-LRB-
ABSTRACT_NN
TRUNCATED_VBN
AT_IN
400_CD
WORDS_NNS
-RRB-_-RRB-

